I-Mab
AbbVie Withdraws from CD47 Arena, Ending Partnership with I-Mab
Anika Sharma
AbbVie has officially distanced itself from I-Mab, withdrawing from a once-promising collaboration focused on the anti-CD47 antibody lemzoparlimab, leaving I-Mab ...
